Public Sector Pension Investment Board Biocryst Pharmaceuticals Inc Transaction History

Public Sector Pension Investment Board

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.6 - $4.11 $78,081 - $200,572	-48,801 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.59 - $3.45 $588,139 - $1.28 Million	-369,899 Reduced 88.34%	48,801 $168,000
Q3 2019 Nov 14, 2019	BUY	$2.5 - $3.73 $1.05 Million - $1.56 Million	418,700 New	418,700 $1.2 Million

285

171M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.62B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.